Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples